微导管辅助小梁切开术治疗斯特奇-韦伯综合征及色素血管性斑痣性错构瘤病相关青光眼的结局
回顾性非对照介入病例系列纳入北京儿童医院2017年8月至2020年4月接受外路微导管辅助小梁切开术(MAT)的SWS相关青光眼13眼(12例)和PPV相关青光眼9眼(8例),平均手术年龄12.8±15.8个月,平均随访39.5±10.4个月。SWS组和PPV组眼压均较基线显著下降,42个月完全(条件)成功率分别为76.2%(87.5%)和22.2%(40.0%),并发症轻微,PPV与更差的手术结局相关。
要点
- 外路MAT对SWS相关早发性青光眼有效且安全,但部分患者眼压随时间逐渐升高。
- 外路MAT对PPV相关早发性青光眼中期疗效有限。
- PPV与更差的手术结局相关。
核心结论
- 外路MAT是SWS相关早发性青光眼有效且安全的治疗,但部分患者眼压随时间逐渐升高。
- 外路MAT对PPV相关早发性青光眼的中期疗效有限。
- PPV与更差的手术结局相关。
研究设计与样本
- 回顾性、非对照、介入性病例系列,纳入2017年8月至2020年4月在北京儿童医院接受外路MAT的连续SWS或PPV相关青光眼患者。
- 共纳入SWS 13眼(12例)和PPV 9眼(8例),手术时平均年龄12.8±15.8个月,平均随访39.5±10.4个月。
- 成功定义为眼压<21 mmHg,使用抗青光眼药物为条件成功,不使用为完全成功。
主要发现
- SWS组眼压从基线26.5±5.3 mmHg降至末次随访16.5±5.0 mmHg(P < .001)。
- PPV组眼压从基线29.2±7.5 mmHg降至末次随访23.4±4.7 mmHg(P = .014)。
- 42个月时Kaplan-Meier完全(条件)成功率:SWS眼为76.2%(87.5%),PPV眼为22.2%(40.0%)。
- 并发症轻微。
关键数值与推荐
- 成功定义为眼压<21 mmHg,使用抗青光眼药物为条件成功,不使用为完全成功。
- 42个月完全(条件)成功率:SWS眼76.2%(87.5%),PPV眼22.2%(40.0%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate mid-term efficacy and safety of ab externo Microcatheter-assisted trabeculotomy (MAT) for early-onset glaucoma associated with Sturge-Weber syndrome (SWS) and phakomatosis pigmentovascularis (PPV). DESIGN: Retrospective, non-comparative, interventional case series. METHODS: Medical records of consecutive SWS- or PPV-associated glaucoma patients who had undergone ab externo MAT between August 2017 and April 2020 at Beijing Children's Hospital were reviewed. Success was defined as an intraocular pressure (IOP) of <21 mmHg with (qualified success) or without (complete success) the use of antiglaucoma medication. RESULTS: Overall, 13 eyes (12 patients) with SWS and 9 eyes (8 patients) with PPV were included, with a mean age of 12.8 ± 15.8 months at the time of surgery and a mean follow-up time of 39.5 ±10.4 months. Both the SWS (26.5 ± 5.3 mmHg at baseline vs 16.5 ± 5.0 mmHg at the last visit; P < .001) and PPV (29.2 ± 7.5 mmHg vs 23.4 ± 4.7 mmHg; P = .014) subsets achieved a statistically significant fall in IOP following surgery. The Kaplan-Meier survival rate of complete (qualified) success after 42 months was 76.2% (87.5%) and 22.2% (40.0%) for eyes with SWS and PPV, respectively. Complications were minimal. Phakomatosis pigmentovascularis was associated with worse surgical outcomes. CONCLUSIONS: Ab externo MAT is an effective and safe treatment for early-onset glaucoma associated with SWS, but a gradual increase in IOP over time was noted in some patients. Ab externo MAT has limited efficacy for early-onset glaucoma associated with PPV in the mid-term.
引用
- Hu M, Liang T, Leng F, et al. Outcomes of Microcatheter-Assisted Trabeculotomy for Glaucoma Associated With Sturge-Weber Syndrome and Phakomatosis Pigmentovascularis. Am J Ophthalmol. 2022. PMID: 36513156. doi:10.1016/j.ajo.2022.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。